Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 354-359

  Brizzolara Gourdie, Antonia ^a   Webb, Jerry G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BUCLADESINE; CYCLIC AMP; ILOPROST; ISOPRENALINE; PHENYLEPHRINE; PROSTACYCLIN DERIVATIVE;

ANIMAL TISSUE; AORTA MEDIA; ARTERY TONE; ARTICLE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE RELAXATION; VASODILATATION;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CYCLIC AMP; CYCLIC GMP; ISOPROTERENOL; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0030924647     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ALTURA, B. M. AND ALTURA, B. T.: Vascular smooth muscle and neurohypophyseal hormones. Fed. Proc. 36: 1853-1860, 1977.
2. BAUKAL, A. J., HUNYADY, L., GATT, K. J. AND BALLA, T.: Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II. J. Biol. Chem. 269: 24546-24549, 1994.
3. BOLTON, T. B.: Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59: 606-718, 1979.
4. BRAMI, B., VILGRAIN, I. AND CHAMBAZ, E. M.: Sensitization of adrenocortical cell adenylate cyclase activity to ACTH by angiotensin II and activators of protein kinase C. Mol. Cell. Endocrinol. 50: 131-137, 1987.
5. BÜLBRING, E.: Measurements of oxygen consumption in smooth muscle. J. Physiol. 122: 111-134, 1953.
6. CHOI, E. J., XIA, Z. AND STORM, D. R.: Stimulation of the type III olfactory adenylyl cylcase by calcium and calmodulin. Biochemistry 31: 6492-6498, 1992.
7. ECKLY, A. E., STOCLET, J. C. AND LUGNIER, C.: Isoprenaline induces endothelium-independent relaxation and accumulation of cyclic nucleotides in the rat aorta. Eur. J. Pharmacol. 271: 237-240, 1994.
8. JIANG, H., COLBRAN, J. L., FRANCIS, S. H. AND CORBIN, J. D.: Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J. Biol. Chem. 267: 1015-1019, 1992.
9. KUBALAK, S. W. AND WEBB, J. G.: Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells. Am. J. Physiol. 264: H86-H96, 1993.
10. KUKOVETZ, W. R., HOLZMANN, S., WURM, A. AND POCH, B.: Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 310: 129-138, 1979.
11. LEGAN, E., CHERNOW, B., PARRILLO, J. AND ROTH, B. L.: Activation of phosphatydylinositol turnover in rat aorta by α1-adrenergic receptor stimulation. Eur. J. Pharmacol. 110: 389-390, 1985.
12. 2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol. 258: C399-C407, 1990.
13. LINCOLN, T. M. AND FISHER-SIMPSON, V.: A comparison of the effects of forskolin and nitroprusside on cyclic nucleotides and relaxation in the rat aorta. Eur. J. Pharmacol. 101: 17-27, 1983.
14. MANOLOPOULOS, V. G., PIPILI-SYNETOS, E., DEN HERTOG, A. AND NELEMANS, A.: Inositol phosphates formed in rat aorta after alpha 1-adrenoceptor stimulation are inhibited by forskolin. Eur. J. Pharmacol. 207: 29-36, 1991.
15. MASAKI, T., VANE, J. R. AND VANHOUTTE, P. M.: International Union of Pharmacology nomenclature on endothelin receptors. Pharmacol. Rev. 46: 137-142, 1994.
16. MILLER, R. C., PELTON, J. C. AND HUGGINS, J. P.: Endothelins: From receptors to medicine. Trends Pharmacol. Sci. 14: 54-60, 1993.
17. MONCADA, S., HERMAN, A. G., HIGGS, E. A. AND VANE, J. R.: Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of the vascular endothelium. Thrombosis Res. 11: 323-344, 1977.
18. MURAD, F., MITTAL, C. K., ARNOLD, W. P., KATSUKI, S. AND KIMURA, H.: Guanylate cyclase; activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv. Cyclic Nucleotide Res. 9: 145-158, 1978.
19. MURTHY, K. S. AND MAKHLOUF, G. M.: Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am. J. Physiol. 268: C171-C180, 1995.
20. NABIKA, T., VELLETRI, P. A., LOVENBERG, W. AND BEAVEN, M. A.: Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg]vasopressin in vascular smooth muscle cells. J. Biol. Chem. 260: 4661-4670, 1985.
21. RAPOPORT, R. M.; Inhibitory effects of cyclic AMP-elevating agents on norepinephrine-induced phosphatidylinositide hydrolysis and contraction in rat aorta. Gen. Pharmacol. 22: 449-458, 1991.
22. SOMLYO, A. P. AND SOMLYO, A. V.: Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
23. SOMLYO, A. V., BOND, M., SOMLYO, A. P. AND SCARPA, A.: Inositol triphosphate-induced calcium release and contraction in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 82: 5231-5235, 1985.
24. SUNGA, P. S. AND RABKIN, S. W.: Angiotensin II induced alteration of cyclic adenosine 3′,5′-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet. Can. J. Physiol. Pharmacol. 72: 602-612, 1994.
25. TACHADO, S. D., AKHTAR, R. A. AND ABDEL-LATIF, A. A.: Activation of beta-adrenergic receptors causes stimulation of cyclic AMP, inhibition of inositol triphosphate, and relaxation of bovine iris sphincter smooth muscle. Biochemical and functional interactions between the cAMP and calcium signalling systems. Invest. Opthalmol. Vis. Sci. 30: 2232-2239, 1989.
26. TACHADO, S. D., AKHTAR, R. A., ZHOU, C. J. AND ABDEL-LATIF, A. A.: Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol triphosphate production, and contraction in bovine iris sphincter smooth muscle: interaction between cAMP and IP3 second messenger systems. Cell Signal. 4: 61-75, 1992.
27. URQUHART, R. A. AND BROADLEY, K. J.: Comparison of adenosine receptor agonists with other vasodilators on noradrenaline-, potassium- and phorbol ester-contracted rabbit aorta. Eur. J. Pharmacol. 200: 35-43, 1991.
28. VANECEK, J., SUGDEN, D., WELLER, J. AND KLEIN, D. C.: Atypical synergintic α1-β1-adrenergic regulation of adenosine 3′,5′-monophosphate and guanoaine 3′,5′-monophosphate in rat pinealocytes. Endocrinology 116: 2167-2173, 1985.
29. VILLALOBOS-MOLINA, R., UC, E., HONG, E. AND GARCIA-SAINZ, J. A.: Correlation between phosphatydylinositol labelling and contraction in rabbit aorta: Effect of alpha-1-adrenergic activation. J. Pharmacol. Exp. Ther. 222: 258-261, 1982.
30. WEBB, J. G., SATO, M., DUZIC, E. AND LANIER, S. M.: Role of type III adenylyl cyclase in angiotension II enhancement of hormone-stimulated cAMP formation. FASEB J. 9: A42, 1995.
31. WEBB, R. C.: Angiotensin II-induced relaxation of vascular smooth muscle. Blood Vessels 19: 165-176, 1982.
32. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAKAZI, Y., GOTO, K. AND MASAKI, T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.